TotalMarketCap

Harrow

HROWNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$975.059 M

$26.01 -9.53%

Close of 6 Nov 2026

As of 6 Nov 2026, Harrow (HROW) has a market capitalization of $975.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$272.3M

#2161 by revenue

Earnings

-$5.14M

Loss-making

Shares outstanding

37,487,850

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #143Seaport TherapeuticsSPTX$1.09B
  2. #144Janux TherapeuticsJANX$985.5M
  3. #145HarrowHROW$975.1M
  4. #146MoonLake ImmunotherapeuticsMLTX$919.6M
  5. #147SavaraSVRA$896.8M

What if Harrow were worth as much as…

Open the what-if tool →

Gold $28.2T

$753,227.35

Per share 28,959× higher

Bitcoin $1.53T

$40,755.82

Per share 1,567× higher

Apple $5.02T

$133,797.55

Per share 5,144× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Harrow are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.